Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect

NCT00988494 is registered in ClinicalTrials.gov with Santen Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT00988494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect
Lead sponsor
Santen Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
Not reported
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent corneal epithelial defect